IAC Express 2007
Issue number 698: December 3, 2007
 
Contents of this Issue
Select a title to jump to the article.
  1. December 6 conference call offers practical strategies for vaccinating throughout the 2007-08 influenza season
  2. VIS for intranasal influenza vaccine now available in Spanish and Cambodian
  3. New: Two IAC screening questionnaires on precautions and contraindications to vaccination now available in more languages
  4. IAC updates a piece that answers patients' and parents' questions about influenza
  5. IAC updates its "Guide to Contraindications and Precautions to Commonly Used Vaccines in Adults"
  6. CDC reports on global progress on measles control and mortality reduction during 2000-2006
  7. CDC series on Epidemiology and Prevention of VPDs ceases live broadcast; will be available on DVD and Internet only
  8. MMWR announces that December 1 marked the twentieth anniversary of World AIDS Day
  9. National Influenza Vaccination Week organizers thank partners and encourage on-going use of resources
  10. GAO publishes the findings of its study on influenza vaccine production, distribution, and promotion
  11. Important: Be sure to give influenza vaccine throughout the influenza season--from fall 2007 through spring 2008
 
Abbreviations
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
  
Issue 698: December 3, 2007
1.  December 6 conference call offers practical strategies for vaccinating throughout the 2007-08 influenza season

The National Influenza Vaccine Summit and CDC have scheduled a conference call, "Breaking from your Comfort Zone--Extending the Influenza Vaccination Season," on December 6 at noon ET. Scheduled speakers include practicing family physician Dr. Andrew Eisenberg, who will offer healthcare professionals real-world strategies for keeping influenza vaccination in the forefront of their practices.

In addition to Dr. Eisenberg, presenters include Dr. Andrew Kroger, a medical officer and trainer at CDC's Immunization Services Division, who will moderate; Diane Peterson, associate director for immunization projects, Immunization Action Coalition, who will speak on behalf of the Summit; and Dr. Jeanne Santoli, deputy director, CDC's Immunization Services Division, who will take questions.

For phone information and additional details, go to:
http://www.cdc.gov/vaccines/ed/ciinc/calls/flucall.htm

Back to top
   
2 VIS for intranasal influenza vaccine now available in Spanish and Cambodian

The current version (dated 10/4/07) of the VIS for live attenuated influenza vaccine (LAIV; nasal spray) is now available on the IAC website in Spanish and Cambodian. IAC gratefully acknowledges the California Department of Health Services for the translations.

To obtain a ready-to-print (PDF) version of the VIS for LAIV vaccine in Spanish, go to:
http://www.immunize.org/vis/spliveflu06.pdf

To obtain the VIS for LAIV vaccine in Cambodian, go to:
http://www.immunize.org/vis/caLAIV04.pdf

To obtain the VIS for LAIV vaccine in English, go to:
http://www.immunize.org/vis/liveflu.pdf

For information about the use of VISs, and for VISs in more than 30 languages, visit IAC's VIS web section at http://www.immunize.org/vis

Back to top
   
3 New: Two IAC screening questionnaires on precautions and contraindications to vaccination now available in more languages

IAC is now offering the following screening questionnaires in languages in addition to English: "Screening Questionnaire for Injectable Influenza Vaccine" (available in Spanish) and "Screening Questionnaire for Adult Immunization" (available in Spanish, and also in Arabic, Chinese, French, Korean, Russian, and Vietnamese).

"SCREENING QUESTIONNAIRE FOR INJECTABLE INFLUENZA VACCINE"
To access a ready-to-print (PDF) version of "Screening Questionnaire for Injectable Influenza Vaccine" in Spanish, go to:
http://www.immunize.org/catg.d/p4066-01.pdf

To access a ready-to-print (PDF) version of "Screening Questionnaire for Injectable Influenza Vaccine" in English, go to:
http://www.immunize.org/catg.d/p4066.pdf

"SCREENING QUESTIONNAIRE FOR ADULT IMMUNIZATION"
To access a ready-to-print (PDF) version of "Screening Questionnaire for Adult Immunization" in Spanish, go to:
http://www.immunize.org/catg.d/p4065-01.pdf

To access a ready-to-print (PDF) version of "Screening Questionnaire for Adult Immunization" in Arabic, go to:
http://www.immunize.org/catg.d/p4065-20.pdf

To access a ready-to-print (PDF) version of "Screening Questionnaire for Adult Immunization" in Chinese, go to:
http://www.immunize.org/catg.d/p4065-08.pdf

To access a ready-to-print (PDF) version of "Screening Questionnaire for Adult Immunization" in French, go to:
http://www.immunize.org/catg.d/p4065-10.pdf

To access a ready-to-print (PDF) version of "Screening Questionnaire for Adult Immunization" in Korean, go to:
http://www.immunize.org/catg.d/p4065-09.pdf

To access a ready-to-print (PDF) version of "Screening Questionnaire for Adult Immunization" in Russian, go to:
http://www.immunize.org/catg.d/p4065-07.pdf

To access a ready-to-print (PDF) version of "Screening Questionnaire for Adult Immunization" in Vietnamese, go to:
http://www.immunize.org/catg.d/p4065-05.pdf

To access a ready-to-print (PDF) version of "Screening Questionnaire for Adult Immunization" in English, go to:
http://www.immunize.org/catg.d/p4065.pdf

Back to top
   
4 IAC updates a piece that answers patients' and parents' questions about influenza

IAC recently updated its comprehensive influenza Q&A piece for patients and parents, "Influenza: Questions and Answers." The piece now incorporates the most recent changes regarding use of the live attenuated influenza vaccine (LAIV; nasal-spray formulation), as well as other changes.

To access "Influenza: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4208.pdf

The influenza Q&A is one of a series of Q&As intended to be printed out and handed to patients and parents to help educate them about the seriousness of VPDs and the importance of vaccination.

To access the complete disease/vaccine Q&A series for patients and parents, go to: http://www.vaccineinformation.org and click on the pertinent VPD

Back to top
   
5 IAC updates its "Guide to Contraindications and Precautions to Commonly Used Vaccines in Adults"

IAC recently revised its one-page professional-education piece "Guide to Contraindications and Precautions to Commonly Used Vaccines in Adults." The piece now incorporates the most recent changes regarding use of the live attenuated influenza vaccine (LAIV; nasal-spray formulation), as well as other changes.

To access the revised piece, go to:
http://www.immunize.org/catg.d/p3072.pdf

Back to top
   
6 CDC reports on global progress on measles control and mortality reduction during 2000-2006

CDC published "Progress in Global Measles Control and Mortality Reduction, 2000-2006" in the November 30 issue of MMWR. Portions of the article are reprinted below.


The World Health Organization (WHO) and United Nations Children's Fund (UNICEF) comprehensive strategy for measles mortality reduction is focused on 47 priority countries. Components include (1) achieving and maintaining high coverage (>90%) with the first dose of measles vaccine by age 12 months in every district of each priority country through routine immunization services; (2) ensuring that all children receive a second opportunity for measles vaccination; (3) maintaining effective case-based surveillance and monitoring of vaccination coverage; and (4) providing appropriate clinical management, including vitamin A supplementation. In 2005, the World Health Assembly set a goal for global measles control as part of the Global Immunization Vision and Strategy (GIVS): a 90% reduction in measles mortality by 2010, compared with 2000 levels. In January 2007, WHO/UNICEF reported that implementation of measles mortality reduction strategies had reduced measles mortality by 60%, from an estimated 873,000 deaths in 1999 to 345,000 deaths in 2005. This reduction exceeded the goal of 50% measles mortality reduction by 2005 (compared with 1999 levels) that had been set in 2002. This report updates previous reports by detailing (1) measles mortality reduction activities implemented during 2006 and (2) the impact of activities since 2000 on the global burden of measles and progress toward the GIVS mortality reduction goal for 2010.

Immunization Activities
WHO/UNICEF produces estimates of routine coverage with a single dose of measles vaccine on the basis of data from administrative records and surveys. Measles vaccination coverage levels achieved during supplementary immunization activities (SIAs) are estimated from the reported number of doses administered divided by the target population.

According to WHO/UNICEF estimates, global routine first-dose measles vaccination coverage reached 80% for the first time in 2006, increasing from 72% in 2000. Coverage varied substantially by WHO region. From 2000 to 2006, the greatest improvements in routine coverage were observed in the WHO Africa Region (from 56% to 73%), the Eastern Mediterranean Region (73% to 83%), and the Western Pacific Region (86% to 93%). Despite this progress, in 2006, an estimated 26.2 million (20%) infants worldwide missed receiving their first dose of measles vaccine through routine immunization services by age 12 months (or by the time of vaccination if first dose was scheduled after 12 months). Of these, 12.8 million (49%) resided in the WHO South-East Asia Region, 7.5 million (29%) in the Africa Region, 2.3 million (9%) in the Eastern Mediterranean Region, and 1.8 million (7%) in the Western Pacific Region. . . .

Mortality Estimates for 2006
Despite the global progress in measles surveillance and reporting, complete and reliable data on the number of measles deaths is lacking in many countries, particularly those with the highest disease burden. . . .

From 2000 to 2006, estimated measles deaths worldwide declined 68%, from 757,000 deaths (uncertainty bounds: 551,000-990,000 deaths) in 2000 to 242,000 deaths (uncertainty bounds: 173,000-325,000 deaths) in 2006. The largest percentage reduction in estimated measles mortality during this period was in the Africa Region (91%), accounting for 70% of the global reduction in measles mortality. . . .

Editorial Note:
Although the WHO/UNICEF measles mortality reduction goal for 2005 was surpassed, major challenges exist to achieving the 2010 GIVS goal of 90% reduction in global measles mortality, and substantial work is required to sustain the gains already made. First, measles mortality reduction activities need to be implemented successfully in several countries with large populations and high measles burdens (e.g., India and Pakistan). Second, to sustain the gains in reduced measles deaths in the 47 priority countries, particularly in the Africa Region, vaccination programs need to be improved to ensure that >90% of infants are vaccinated against measles through routine health services before their first birthday. Third, all priority countries need to conduct follow-up SIAs every 2-4 years until their routine vaccination programs are capable of providing two opportunities for measles vaccination to >90% of all birth cohorts before age 5 years. . . .


To access a web-text (HTML) version of the complete article, go to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5647a3.htm

To access a ready-to-print (PDF) version of this issue of MMWR, go to: http://www.cdc.gov/mmwr/PDF/wk/mm5647.pdf

To receive a FREE electronic subscription to MMWR (which includes new ACIP statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html

Back to top
   
7 CDC series on Epidemiology and Prevention of VPDs ceases live broadcast; will be available on DVD and Internet only

The satellite broadcast series Epidemiology and Prevention of Vaccine-Preventable Diseases has been presented at least once a year since 1995. Because of escalating costs and limited availability of the CDC broadcast facility, the series will no longer be presented as a live broadcast. Beginning in 2008, this training program will be available only on DVD and by Internet. The 2008 series is expected to be available in late spring. Future issues of NCIRD's electronic newsletter Immunization Works and IAC's IAC Express will keep readers informed as specific details are made available.

Back to top
   
8 MMWR announces that December 1 marked the twentieth anniversary of World AIDS Day

CDC published "World AIDS Day--December 1, 2007" in the November 30 issue of MMWR. The article is reprinted below in its entirety, excluding references.


December 1 marks the 20th observance of World AIDS Day, an annual worldwide event established to increase awareness and education regarding human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS). In 2007, an estimated 33.2 million persons worldwide are living with HIV; the number of deaths from AIDS in 2007 is expected to total 2.1 million. In the United States, an estimated 1 million persons were living with HIV in 2003; of these, approximately 25% were unaware of their infection and thus were at high risk for infecting others.

HIV testing remains a crucial component of HIV prevention strategies. Persons who know they are infected with HIV can seek health care and protect their partners from becoming infected. In 2006, CDC issued new guidelines recommending routine HIV testing of adults, adolescents, and pregnant women in healthcare settings in the United States. In addition, CDC recently provided funding to increase testing among populations disproportionately affected by HIV/AIDS. Additional information regarding World AIDS Day and HIV prevention measures is available at http://www.cdc.gov/features/worldaidsday and http://www.cdc.gov/hiv


To access a web-text (HTML) version of the complete article, go to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5647a1.htm

To access a ready-to-print (PDF) version of this issue of MMWR, go to: http://www.cdc.gov/mmwr/PDF/wk/mm5647.pdf

Back to top
   
9 National Influenza Vaccination Week organizers thank partners and encourage on-going use of resources

The National Influenza Vaccine Summit (NIVS), a primary organizer of National Influenza Vaccination Week (NIVW), recently extended thanks to the many partners who participated in NIVW activities. The Summit wrote the following:

"Together, we have made another important step toward promoting a longer vaccination season, enabling us to protect more children, adolescents, and adults against influenza. We look forward to continuing this tradition in 2008 with the third annual National Influenza Vaccination Week. It is our hope that next year's effort will have an even greater impact, and that we will be able to work even more closely with the same thoughtful and dedicated group of partners in planning and implementing NIVW activities."

NIVS also encourages participants to keep disseminating information about influenza vaccination throughout the 2007-08 influenza season. Following are links to information that is updated frequently. Be sure to encourage patients and staff to check them often.

To learn more about seasonal influenza go to:
http://www.cdc.gov/flu
http://www.preventinfluenza.org
http://www.facesofinfluenza.org/home.php

To find a flu clinic, go to: http://www.flucliniclocator.org

To find vaccine for your clinic, go to: http://www.preventinfluenza.org/ivats Click on the link to the Microsoft Excel spreadsheet

To make vaccine available on the Microsoft Excel spreadsheet above (vaccine manufacturers and distributors), click on the IVATS enrollment link.

Back to top
   
10.  GAO publishes the findings of its study on influenza vaccine production, distribution, and promotion

In October 2007, the Government Accountability Office published the findings of its study on influenza vaccine production, distribution, and promotion. Titled "Influenza Vaccine: Issues related to production, distribution, and public health messages," it is available for downloading.

To access the full document, as well as the document's abstract and highlights, go to:
http://www.gao.gov/docsearch/abstract.php?rptno=GAO-08-27

Back to top
   
11.  Important: Be sure to give influenza vaccine throughout the influenza season--from fall 2007 through spring 2008

Influenza vaccination should continue from now into the early months of 2008. Visit the following websites often to find the information you need to keep vaccinating. Both are continually updated with the latest resources.

The National Influenza Vaccine Summit website at http://www.preventinfluenza.org

CDC's Seasonal Flu web section at http://www.cdc.gov/flu

Back to top
   

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .